Table 3.
Target trough level of TAC | CYP3A5 expressers | CYP3A5 non-expressers | ||||||
---|---|---|---|---|---|---|---|---|
MMF 250 mg bid | MMF 500 mg bid | MMF 750 mg bid | MMF 1 g bid | MMF 250 mg bid | MMF 500 mg bid | MMF 750 mg bid | MMF 1 g bid | |
3–4 ng/mL | 2 mg bid | 1.5 mg bid | 1 mg bid | 1 mg bid | 1 mg bid | 1 mg bid | 0.5 mg bid | 0.5 mg bid |
4–5 ng/mL | 2.5 mg bid | 2 mg bid | 2 mg bid | 1 mg bid | 1.5 mg bid | 1 mg bid | 1 mg bid | 0.5 mg bid |
5–7 ng/mL | 3 mg bid | 2.5 mg bid | 2 mg bid | 1.5 mg bid | 2 mg bid | 1.5 mg bid | 1 mg bid | 1 mg bid |
bid, twice daily; CYP3A5 expresser, CYP3A5*1/*1 or CYP3A5*1/*3 carriers; CYP3A5 non-expresser, CYP3A5*3/*3 carriers; MMF, mycophenolate mofetil; TAC, tacrolimus.